Agios Pharmaceuticals, Inc. financial data

Symbol
AGIO on Nasdaq
Location
88 Sidney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.43K % +34.7%
Quick Ratio 43.1 % +40.6%
Debt-to-equity 7.32 % -44.8%
Return On Equity -28.4 % -140%
Return On Assets -26.4 % -143%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.3M shares +2.25%
Common Stock, Shares, Outstanding 58.3M shares +2.21%
Entity Public Float 2.42B USD +55.1%
Weighted Average Number of Shares Outstanding, Basic 58.1M shares +2.11%
Weighted Average Number of Shares Outstanding, Diluted 58.1M shares -0.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 44.8M USD +36.3%
Research and Development Expense 334M USD +12.9%
Costs and Expenses 520M USD +18.3%
Operating Income (Loss) -476M USD -16.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -103M USD -110%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -401M USD -160%
Earnings Per Share, Basic -6 USD/shares -159%
Earnings Per Share, Diluted -6 USD/shares -159%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.7M USD -63.5%
Cash, Cash Equivalents, and Short-term Investments 1.3B USD -23.5%
Inventory, Net 32M USD +21.2%
Assets, Current 1.03B USD -3.82%
Property, Plant and Equipment, Net 10.7M USD -9.68%
Operating Lease, Right-of-Use Asset 33.7M USD -26.6%
Other Assets, Noncurrent 3.93M USD -3.11%
Assets 1.39B USD -22.7%
Accounts Payable, Current 19.6M USD +14.1%
Employee-related Liabilities, Current 19.6M USD +10.8%
Accrued Liabilities, Current 37.2M USD +11.7%
Liabilities, Current 74.8M USD -37.4%
Operating Lease, Liability, Noncurrent 26.5M USD -40.4%
Other Liabilities, Noncurrent 90K USD -92.2%
Liabilities 101M USD -38.6%
Retained Earnings (Accumulated Deficit) -454M USD -766%
Stockholders' Equity Attributable to Parent 1.28B USD -21%
Liabilities and Equity 1.39B USD -22.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -111M USD -11.6%
Net Cash Provided by (Used in) Financing Activities 1.62M USD -72.4%
Net Cash Provided by (Used in) Investing Activities 113M USD -9.61%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 74.5M shares +1.72%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.72M USD -91.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 92.7M USD -63.5%
Deferred Tax Assets, Valuation Allowance 276M USD -27.4%
Deferred Tax Assets, Gross 287M USD -27.2%
Operating Lease, Liability 44.5M USD -26.8%
Payments to Acquire Property, Plant, and Equipment 766K USD +443%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -403M USD -159%
Lessee, Operating Lease, Liability, to be Paid 47.7M USD -28.9%
Property, Plant and Equipment, Gross 68.2M USD +0.83%
Operating Lease, Liability, Current 18M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.8M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.2M USD +3.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.15M USD -49.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.48M USD -83.2%
Deferred Tax Assets, Operating Loss Carryforwards 26.5M USD -58.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 31.6M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.48M USD -83.2%
Operating Lease, Payments 19.4M USD +4.22%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 49.3M USD +7.81%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%